Latha Sridharan

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert et al. · Blood · 2003 · 354 citations · Full text

SKI-606, a Src/Abl Inhibitor with<i>In vivo</i>Activity in Colon Tumor Xenograft Models

Jennifer M. Golas, Judy Lucas, Carlo Etienne et al. · Cancer Research · 2005 · 133 citations · Full text

Cancer Biology, Tumor Biology, Signaling Pathway +18

Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells

Marc Damelin, Kenneth G. Geles, Maximillian T. Follettie et al. · Cancer Research · 2011 · 79 citations

Cancer Immunosurveillance, Tumor Heterogeneity, Tumor-initiating Cells +14

Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture

Shuang Chen, Andreas Giannakou, Sarah Wyman et al. · Proceedings of the National Academy of Sciences · 2018 · 65 citations · Full text

Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193-<b> <i>N</i> </b>-Acetyl γ Calicheamicin Dimethyl Hydrazide Targets Lewisy and Eliminates Lewisy-Positive Human Carcinoma Cells and Xenografts

Erwin R. Boghaert, Latha Sridharan, Douglas Armellino et al. · Clinical Cancer Research · 2004 · 64 citations · Full text